Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Caffeine in the Second Stage: A Randomized Control Trial in Low-risk Nulliparous Mothers at Term

NCT05906303 is registered in ClinicalTrials.gov with The Reading Hospital and Medical Center as lead sponsor.

NCT NCT05906303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05906303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Caffeine in the Second Stage: A Randomized Control Trial in Low-risk Nulliparous Mothers at Term
Lead sponsor
The Reading Hospital and Medical Center
Phase
Phase 1
Overall status
Unknown status
Start date
December 1, 2023
Completion date
February 1, 2025
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

second stage of labor